ERBB2 and ovarian cancer: In contrast, analysis of 148 ovarian tumor samples showed that there was no correlation between the expression of CXCR4 and HER2 overexpression; however, overexpression of HER2 had a strong association with overall survival in ovarian cancer patients [95].